ACS (Acute Coronary Syndrome) Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting acs (acute coronary syndrome) clinical trials across 5 countries. Studies span Not Applicable, Phase 4. Top locations include Altamura, BA, Italy, Amsterdam, Netherlands, Arzignano, VI, Italy. Updated daily from ClinicalTrials.gov.


ACS (Acute Coronary Syndrome) Trials at a Glance

7 actively recruiting trials for acs (acute coronary syndrome) are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Altamura, Amsterdam, and Arzignano. Lead sponsors running acs (acute coronary syndrome) studies include Heart Care Foundation, Hochgebirgsklinik Davos, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse acs (acute coronary syndrome) trials by phase

About ACS (Acute Coronary Syndrome) Clinical Trials

Looking for clinical trials for ACS (Acute Coronary Syndrome)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ACS (Acute Coronary Syndrome) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ACS (Acute Coronary Syndrome) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin

ACS (Acute Coronary Syndrome)HF - Heart Failure
Xiling Qi65 enrolled1 locationNCT07486791
Recruiting

European Unified Registries for Heart Care Evaluation and Randomised Trials Italy

ACS (Acute Coronary Syndrome)
Heart Care Foundation5,000 enrolled57 locationsNCT07283809
Recruiting

Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons

PaclitaxelACS (Acute Coronary Syndrome)CAD - Coronary Artery Disease+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3,000 enrolled1 locationNCT07231835
Recruiting

TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevation Acute Coronary Syndrome

Myocardial Infarction (MI)Inflammation BiomarkersSTEMI+3 more
University Hospital Centre Mother Teresa1,600 enrolled1 locationNCT07026708
Recruiting

Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery

Heart FailureArrhythmiaCardiac Arrest (CA)+6 more
Hochgebirgsklinik Davos10,000 enrolled1 locationNCT07096973
Recruiting
Not Applicable

Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients

ACS (Acute Coronary Syndrome)
Shanghai Tongji Hospital, Tongji University School of Medicine380 enrolled1 locationNCT07064109
Recruiting
Phase 4

CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention

ACS (Acute Coronary Syndrome)CYP2C19 Polymorphism
Zunyi Medical College1,200 enrolled1 locationNCT06283888